The Wall Street Journal: McKinsey reaches $573 million settlement with states over its work to boost OxyContin sales

United States

Consulting giant McKinsey & Co. has reached a $ 573 million settlement with states over its work advising OxyContin maker Purdue Pharma LP and other drug manufacturers to aggressively market opioid painkillers, according to people familiar with the matter.

The deal, reached with 47 states and expected to be publicly announced Thursday, would avert civil lawsuits that attorneys general could bring against McKinsey, the people said. The majority of the money will be paid upfront, with the rest dispensed over the next few years.